학술논문

Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension
Document Type
article
Author
Teckman, JeffreyRosenthal, PhilipHawthorne, KieranSpino, CathieBass, Lee MMurray, Karen FKerkar, NandaMagee, John CKarpen, SaulHeubi, James EMolleston, Jean PSquires, Robert HKamath, Binita MGuthery, Stephen LLoomes, Kathleen MSherker, Averell HSokol, Ronald JChiLDReNAlonso, EstellaBass, LeeKelly, SusanRiordan, MaryMelin-Aldana, HectorBezerra, JorgeBove, KevinHeubi, JamesMiethke, AlexanderTiao, GregDenlinger, JulieChapman, ErinSokol, RonaldFeldman, AmyMack, CaraNarkewicz, MichaelSuchy, FrederickSundaram, ShikhaVan Hove, JohanGarcia, BenignoKauma, MikaelaKocher, KendraSteinbeiss, MatthewLovell, MarkLoomes, KathleenPiccoli, DavidRand, ElizabethRusso, PierreSpinner, NancyErlichman, JessiStalford, SamanthaPakstis, DinaKing, SakyaSquires, RobertSindhi, RakeshVenkat, VeenaBukauskas, KathyMcKiernan, PatrickHaberstroh, LoriSquires, JamesBull, LauraCurry, JoannaLanglois, CamilleKim, GraceTeckman, JefferyKociela, VikkiNagy, RosemaryPatel, ShraddhaCerkoski, JacquelineBozic, MollySubbarao, GirishKlipsch, AnnSawyers, CindyCummings, OscarHorslen, SimonMurray, KarenHsu, EvelynCooper, KaraYoung, MelissaFinn, LauraKamath, BinitaNg, VickyQuammie, ClaudiaPutra, JuanSharma, DeepikaParmar, AishwaryaGuthery, StephenJensen, KyleRutherford, AnnLowichik, AmyBook, LindaMeyers, RebeckaHall, TylerWang, KasperMichail, SoniaThomas, DannyGoodhue, CatherineKohli, RohitWang, LarrySoufi, Nisreen
Source
Subject
Paediatrics
Biomedical and Clinical Sciences
Digestive Diseases
Liver Disease
Pediatric
Hypertension
Clinical Research
Rare Diseases
Transplantation
Chronic Liver Disease and Cirrhosis
2.1 Biological and endogenous factors
Aetiology
Oral and gastrointestinal
Good Health and Well Being
Adolescent
Adult
Child
Child
Preschool
Cholestasis
Intrahepatic
Disease Progression
Female
Humans
Hypertension
Portal
Infant
Infant
Newborn
Liver Transplantation
Longitudinal Studies
Male
Young Adult
alpha 1-Antitrypsin Deficiency
ChiLDReN
cirrhosis
jaundice
liver enzymes
liver transplant
metabolic liver disease
Human Movement and Sports Sciences
Paediatrics and Reproductive Medicine
Pediatrics
Language
Abstract
ObjectivesTo identify predictors of portal hypertension, liver transplantation, and death in North American youth with alpha-1-antitrypsin (AAT) deficiency, and compare with patients with AAT deficiency elsewhere.Study designThe Childhood Liver Disease Research Network Longitudinal Observational Study of Genetic Causes of Intrahepatic Cholestasis is a prospective, cohort study of pediatric cholestatic liver diseases, including AAT deficiency, enrolling PIZZ and PISZ subjects 0-25 years of age seen since November 2007 at 17 tertiary care centers in the US and Canada. Data from standard-of-care baseline and annual follow-up visits were recorded from medical records, history, physical examination, and laboratory studies. Participants with portal hypertension were identified based on data collected.ResultsWe enrolled 350 participants (60% male) with a native liver; 278 (79%) entered the cohort without portal hypertension and 18 developed portal hypertension during follow-up. Thirty participants required liver transplantation; 2 patients died during 1077 person-years of follow-up. There was no difference in participants with or without preceding neonatal cholestasis progressing to transplantation or death during the study (12% vs 7%; P = .09), or in experiencing portal hypertension (28% vs 21%; P = .16); the hazard ratio for neonatal cholestasis leading to portal hypertension was P = .04. Development of portal hypertension was associated with a reduced height Z-score.ConclusionsPortal hypertension in youth with AAT deficiency impacts growth measures. Progression to liver transplantation is slow and death is rare, but the risk of complications and severe liver disease progression persists throughout childhood. A history of neonatal cholestasis is a weak predictor of severe disease.